The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia

Hajime Yamauchi, Takanori Matsumaru, Tomoko Morita, Susumu Ishikawa, Katsumi Maenaka, Ichigaku Takigawa, Kentaro Senba, Shunsuke Kon, Yasuyuki Fujita

    Research output: Contribution to journalArticle

    9 Citations (Scopus)

    Abstract

    Recent studies have revealed that cell competition can occur between normal and transformed epithelial cells; normal epithelial cells recognize the presence of the neighboring transformed cells and actively eliminate them from epithelial tissues. Here, we have established a brand-new high-throughput screening platform that targets cell competition. By using this platform, we have identified Rebeccamycin as a hit compound that specifically promotes elimination of RasV12-transformed cells from the epithelium, though after longer treatment it shows substantial cytotoxic effect against normal epithelial cells. Among several Rebeccamycin-derivative compounds, we have found that VC1-8 has least cytotoxicity against normal cells but shows the comparable effect on the elimination of transformed cells. This cell competition-promoting activity of VC1-8 is observed both in vitro and ex vivo. These data demonstrate that the cell competition-based screening is a promising tool for the establishment of a novel type of cancer preventive medicine.

    Original languageEnglish
    Article number15336
    JournalScientific Reports
    Volume5
    DOIs
    Publication statusPublished - 2015 Oct 20

    Fingerprint

    Epithelium
    Epithelial Cells
    Preventive Medicine
    Neoplasms

    ASJC Scopus subject areas

    • General

    Cite this

    The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia. / Yamauchi, Hajime; Matsumaru, Takanori; Morita, Tomoko; Ishikawa, Susumu; Maenaka, Katsumi; Takigawa, Ichigaku; Senba, Kentaro; Kon, Shunsuke; Fujita, Yasuyuki.

    In: Scientific Reports, Vol. 5, 15336, 20.10.2015.

    Research output: Contribution to journalArticle

    Yamauchi, Hajime ; Matsumaru, Takanori ; Morita, Tomoko ; Ishikawa, Susumu ; Maenaka, Katsumi ; Takigawa, Ichigaku ; Senba, Kentaro ; Kon, Shunsuke ; Fujita, Yasuyuki. / The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia. In: Scientific Reports. 2015 ; Vol. 5.
    @article{071352b44b6c4582ba0f3f2621c36c38,
    title = "The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia",
    abstract = "Recent studies have revealed that cell competition can occur between normal and transformed epithelial cells; normal epithelial cells recognize the presence of the neighboring transformed cells and actively eliminate them from epithelial tissues. Here, we have established a brand-new high-throughput screening platform that targets cell competition. By using this platform, we have identified Rebeccamycin as a hit compound that specifically promotes elimination of RasV12-transformed cells from the epithelium, though after longer treatment it shows substantial cytotoxic effect against normal epithelial cells. Among several Rebeccamycin-derivative compounds, we have found that VC1-8 has least cytotoxicity against normal cells but shows the comparable effect on the elimination of transformed cells. This cell competition-promoting activity of VC1-8 is observed both in vitro and ex vivo. These data demonstrate that the cell competition-based screening is a promising tool for the establishment of a novel type of cancer preventive medicine.",
    author = "Hajime Yamauchi and Takanori Matsumaru and Tomoko Morita and Susumu Ishikawa and Katsumi Maenaka and Ichigaku Takigawa and Kentaro Senba and Shunsuke Kon and Yasuyuki Fujita",
    year = "2015",
    month = "10",
    day = "20",
    doi = "10.1038/srep15336",
    language = "English",
    volume = "5",
    journal = "Scientific Reports",
    issn = "2045-2322",
    publisher = "Nature Publishing Group",

    }

    TY - JOUR

    T1 - The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia

    AU - Yamauchi, Hajime

    AU - Matsumaru, Takanori

    AU - Morita, Tomoko

    AU - Ishikawa, Susumu

    AU - Maenaka, Katsumi

    AU - Takigawa, Ichigaku

    AU - Senba, Kentaro

    AU - Kon, Shunsuke

    AU - Fujita, Yasuyuki

    PY - 2015/10/20

    Y1 - 2015/10/20

    N2 - Recent studies have revealed that cell competition can occur between normal and transformed epithelial cells; normal epithelial cells recognize the presence of the neighboring transformed cells and actively eliminate them from epithelial tissues. Here, we have established a brand-new high-throughput screening platform that targets cell competition. By using this platform, we have identified Rebeccamycin as a hit compound that specifically promotes elimination of RasV12-transformed cells from the epithelium, though after longer treatment it shows substantial cytotoxic effect against normal epithelial cells. Among several Rebeccamycin-derivative compounds, we have found that VC1-8 has least cytotoxicity against normal cells but shows the comparable effect on the elimination of transformed cells. This cell competition-promoting activity of VC1-8 is observed both in vitro and ex vivo. These data demonstrate that the cell competition-based screening is a promising tool for the establishment of a novel type of cancer preventive medicine.

    AB - Recent studies have revealed that cell competition can occur between normal and transformed epithelial cells; normal epithelial cells recognize the presence of the neighboring transformed cells and actively eliminate them from epithelial tissues. Here, we have established a brand-new high-throughput screening platform that targets cell competition. By using this platform, we have identified Rebeccamycin as a hit compound that specifically promotes elimination of RasV12-transformed cells from the epithelium, though after longer treatment it shows substantial cytotoxic effect against normal epithelial cells. Among several Rebeccamycin-derivative compounds, we have found that VC1-8 has least cytotoxicity against normal cells but shows the comparable effect on the elimination of transformed cells. This cell competition-promoting activity of VC1-8 is observed both in vitro and ex vivo. These data demonstrate that the cell competition-based screening is a promising tool for the establishment of a novel type of cancer preventive medicine.

    UR - http://www.scopus.com/inward/record.url?scp=84944789880&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84944789880&partnerID=8YFLogxK

    U2 - 10.1038/srep15336

    DO - 10.1038/srep15336

    M3 - Article

    C2 - 26480891

    AN - SCOPUS:84944789880

    VL - 5

    JO - Scientific Reports

    JF - Scientific Reports

    SN - 2045-2322

    M1 - 15336

    ER -